770-25-3-801-0438 -National CMOP F0608: FERROUS SULFATE 324MG EC TAB
ID: 36C77025Q0233Type: Solicitation
AwardedMay 29, 2025
$114.8K$114,761
AwardeeNATIONWIDE PHARMACEUTICAL LLC San Antonio TX 78216 USA
Award #:36C77025P0201
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/78d06ba63c844da3828462dea1011f5c/view
Timeline
    Description

    The Department of Veterans Affairs is seeking vendors to provide Ferrous Sulfate 324mg EC tablets for its Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0233. Interested parties must submit a quotation that includes a signed SF1449 cover page, a detailed pricing schedule in Excel format, and relevant certifications, ensuring compliance with the Trade Agreements Act and federal regulations. This procurement is crucial for maintaining the supply of essential pharmaceutical products to VA facilities nationwide, supporting the healthcare needs of veterans. Quotes are due by May 22, 2024, at 4:00 PM CST, and vendors can contact Sarah Fry at sarah.fry2@va.gov or 913-758-9935 for further information.

    Point(s) of Contact
    Sarah Fry
    (913) 758-9935
    sarah.fry2@va.gov
    Files
    Title
    Posted
    S02_Pricing Schedule_Q0233.xlsx
    The document is a Request for Quotation (RFQ) issued by the National CMOP (Consolidated Mail Outpatient Pharmacy) under RFQ number 36C77025Q0233. Vendors are invited to submit quotes for Ferrous Sulfate 324mg EC tablets for multiple CMOP facilities, with a closing date of May 22, 2024, by 4:00 PM CST. Key requirements include a signed SF1449 solicitation cover page, an Excel spreadsheet with detailed pricing, a valid state wholesale distributor license, and a Trade Agreement Certificate. Vendors must ensure that the expiration dates of the quoted pharmaceuticals meet a minimum of one year from the delivery date, and partial deliveries are requested over three months. Additional details include a list of required documentation and compliance with specified trade agreements. The document emphasizes the importance of observing the outlined procedures for submitting bids and fulfilling procurement specifications, which are critical for ensuring the supply of essential medical supplies to VA facilities nationwide.
    S02_RFQ_36C77025Q0233.pdf
    The document outlines a Request for Proposal (RFP) issued by the Department of Veterans Affairs for the procurement of pharmaceutical supplies, specifically Ferrous Sulfate 324MG EC tablets. The solicitation includes specifications such as delivery terms, required documentation, and compliance with federal regulations. Vendors must submit a quotation containing a signed SF1449 cover page, a detailed pricing schedule, and relevant certifications, ensuring adherence to the Trade Agreements Act. The RFP stresses delivery to multiple locations under strict timelines, emphasizing requirements for product labeling, packaging, and compliance with the Drug Supply Chain Security Act. Contractors must also ensure that products meet specified quality standards and handle any recalls appropriately. The document serves to facilitate a competitive bidding process to secure pharmaceutical supplies for the VA's Consolidated Mail Outpatient Pharmacy, aligning with their commitment to provide quality care and adhere to federal procurement standards.
    S03_PRE_SOL_Q0233.pdf
    The Department of Veterans Affairs (VA) is preparing to solicit bids for the procurement of Ferrous Sulfate 324mg EC tablets for various Consolidated Mail Outpatient Pharmacies (CMOP) across multiple locations. The solicitation number is 36C77025Q0233, with responses due by May 22, 2025. The contract involves staggered monthly deliveries starting 10 days after receipt of order, covering a three-month period. The pharmaceuticals will be delivered to seven CMOP facilities, with total quantities ranging from 1,080 to 8,640 units per location, depending on the site. Interested vendors must be registered in SAM.gov and provide specific documentation, including state wholesale distributor licensure, pricing schedules, and OEM authorization if applicable. The overall goal is to ensure compliance with the Drug Supply Chain Security Act (DSCSA) and facilitate timely delivery of needed medications to support VA operations. This presolicitation emphasizes the VA's commitment to consistently sourcing quality pharmaceuticals to assist the health and well-being of veterans.
    Similar Opportunities
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for operational and mailing supplies to support seven Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. The procurement includes a wide range of items such as resealable bags, corrugated boxes, various types of mailers, child-resistant medical pouches, and packaging materials, all of which must adhere to specific material and postal regulations. This contract is crucial for ensuring the efficient operation of CMOP facilities, which play a vital role in delivering medications to veterans. Interested parties should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details, and must review the attached documents, including the pricing schedule and past performance requirements, as submissions are due by the specified deadlines.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    Tucson CMOP COAL TAR 2% SHAMPOO 240ML AND MOISTURIZING LOTION
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought Notice for domestically manufactured pharmaceuticals, specifically COAL TAR 2% SHAMPOO and MOISTURIZING LOTION, for its Consolidated Mail Outpatient Pharmacy (CMOP) program in Tucson, Arizona. This market research effort aims to identify qualified small and large business manufacturers or distributors capable of supplying these products, which are essential for treating various dermatological conditions. Interested parties must respond by December 15, 2025, at 16:00 CDT, providing necessary company information and ensuring registration in SAM, with inquiries directed to Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935. This notice does not guarantee a contract award but facilitates early information exchange.